Brian Barbour
Contributor since: 2015
Latest Articles
Fevertree: Is The Panic Selling Warranted?
Imperial Brands - Highest Dividend Yield In 18 Years Points To Significant Undervaluation
Fever-Tree: Continued Strength For The Premium Market
Rolls Royce: Dividend Cuts Are Not All Bad
Apple Vs. Qualcomm Heats Up
Apple: Not As Bad As It Seems
A Bearish Warning For Apple
The Largest Undeveloped Oil Find In The U.K.
Fevertree Drinks: Can This Stock Fizz Higher?
A Case To Move Away From The S&P 500 And Invest In British Companies
Brexit Backtrack? What Does This Mean For Stocks?
Potential $10.75b Tax Bill For Apple Would Be A Treat For Shareholders
Apple: Doo Wah Didi
Coca-Cola: Struggling To Justify Holding It
Fevertree: Could It Present A Serious Threat To Coca-Cola's Tonic Sales?
Rolls Royce Slashed Their Dividend: Is This Bad For Investors?
Should Younger Investors Follow The Strategy Of Retirees In Allocating Capital?
Portfolio Update: My Buying And Selling During The Current Market Turbulence
25% Allocation To Apple - Too Much Risk?
Young And Cautious Portfolio - One Month On
A Pessimistic View On Big Oil
Aberdeen Asset Management: A Dividend Growth Bargain With High Yield To Add To The Young And Cautious Portfolio
First Portfolio Review - Young And Cautious
SeaWorld: Sinking To The Bottom Of The Pool
Why Dividend Growth Investing Is Not Always Best
DaVita HealthCare Partners: A Stock To Hold For The Next 30 Years
'Dumping Apple Makes Sense For Immediate Growth' - Or Does It?